Immunologically Mediated Mechanisms in Renal Disease

Yang Zhang

doi:10.62051/ijphmr.v1n2.10

Authors

Yang Zhang

DOI:

https://doi.org/10.62051/ijphmr.v1n2.10

Keywords:

Renal Disease, Immunologically Mediated Mechanisms, m6A RNA Methylation, Immune Cells, Therapeutic Targets

Abstract

The immunologically mediated mechanisms within renal diseases represent a complex biological process. This study primarily focuses on analyzing the roles and mechanisms of immune cells, specifically macrophages, T cells, and B cells, in renal pathology. Utilizing a meticulous approach that combines bioinformatics analysis with in vitro experiments, this paper reveals the critical role of m6A RNA methylation modifications in regulating immune cell functions, promoting apoptosis, and inflammatory responses. The results suggest that the interactions among immune cells and their impact on renal health are of significant biological importance, and that the regulation of m6A methylation modifications presents new potential targets for renal disease treatment. However, as the study relies on in vitro experiment results, the findings necessitate further validation through additional animal experiments and clinical trials. Future research should delve deeper into the specific roles and interactions of different immune cells in various renal diseases to develop more effective treatment strategies.

References

Ruiz-Ortega M, Rayego-Mateos S, Lamas S, et al. Targeting the progression of chronic kidney disease [J]. Nature Reviews Nephrology, 2020, 16(5): 269-288.

Barrera-Chimal J, Jaisser F. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets [J]. Diabetes, Obesity and Metabolism, 2020, 22: 16-31.

Gonsalez S R, Cortês A L, da Silva R C, et al. Acute kidney injury overview: from basic findings to new prevention and therapy strategies [J]. Pharmacology & therapeutics, 2019, 200: 1-12.

Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment [J]. BioMed research international, 2021, 2021.

Faas M M, De Vos P. Mitochondrial function in immune cells in health and disease [J]. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2020, 1866(10): 165845.

Matt S M, Gaskill P J. Where is dopamine and how do immune cells see it?: dopamine-mediated immune cell function in health and disease [J]. Journal of Neuroimmune Pharmacology, 2020, 15: 114-164.

Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease [J]. Cell research, 2020, 30(6): 492-506.

Komada T, Muruve D A. The role of inflammasomes in kidney disease [J]. Nature Reviews Nephrology, 2019, 15(8): 501-520.

Kong L, Andrikopoulos S, MacIsaac R J, et al. Role of the adaptive immune system in diabetic kidney disease [J]. Journal of diabetes investigation, 2022, 13(2): 213-226.

Chi M, Ma K, Wang J, et al. The immunomodulatory effect of the gut microbiota in kidney disease [J]. Journal of immunology research, 2021, 2021: 1-16.